Pfizer and BioNTech this week announced early positive results in their ongoing human trials of an experimental COVID-19 vaccine candidate involving 45 test subjects. The companies said people who received two doses of the experimental nucleoside-modified messenger RNA vaccine candidate, BNT162b1, had higher levels of antibodies after 28 days than recovered COVID-19 patients who had […]
Pfizer, BioNTech See Early Positive Results on COVID-19 Vaccine Candidate
Jul01,2020
By 